Get the Stockscreener App
108.66
0.63%
-0.69
Irhythm Holdings Inc stock is traded at $108.66, with a volume of 398.62K.
It is down -0.63% in the last 24 hours and down -2.83% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$109.35
Open:
$110.89
24h Volume:
398.62K
Relative Volume:
0.83
Market Cap:
$3.58B
Revenue:
$787.85M
Net Income/Loss:
$-27.78M
P/E Ratio:
-125.24
EPS:
-0.8676
Net Cash Flow:
$18.75M
1W Performance:
+1.84%
1M Performance:
-2.83%
6M Performance:
-11.38%
1Y Performance:
-39.97%
1-Day Range:
$108.51
$113.00
1-Week Range:
$104.52
$113.00
52-Week Range:
$100.70
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
108.66 | 3.58B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-26 | Initiated | Stephens | Overweight |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
Three reporting persons report shared voting power over the same iRhythm (IRTC) shares. - Stock Titan
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom? - Zacks Investment Research
iRhythm Holdings stock hits 52-week low at $100.70 - Investing.com
Shipping Association of New York and New Jersey Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Personal Data Is Exposed - GlobeNewswire Inc.
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed - GlobeNewswire Inc.
Trinity Capital (NYSE:TRIN) Stock Price - Simply Wall Street
iRhythm Holdings Finalizes Acquisition of Vital Connect Through iRhythm Technologies - Kalkine Media
A heart-monitoring platform can track up to 11 body signals. iRhythm bought VitalConnect. - Stock Titan
iRhythm Holdings, Inc. (IRTC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Patient insurance numbers and birth dates were in data downloaded during iRhythm's cyber incident - Stock Titan
IRhythm Holdings, Inc. (IRTC) Investor Outlook: Potential 61% Upside Amid Innovative Cardiac Solutions - DirectorsTalk Interviews
iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Promising 58% Upside for Healthcare Innovators - DirectorsTalk Interviews
iRhythm Holdings Inc (IRTC) Stock Down 5.6% -- Now Undervalued? GF Score: 79/100 - GuruFocus
iRhythm Holdings Market Sentiment - Benzinga España
IRhythm Holdings, Inc. (IRTC): Analyst Ratings Signal A Promising 43% Upside For Investors - DirectorsTalk Interviews
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated? - Yahoo Finance
iRhythm CFO Daniel G. Wilson Sells 773 Shares to Cover RSU Tax Withholding - Kalkine Media
Tax-withholding stock sale by iRhythm (IRTC) CFO - Stock Titan
iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 46% Upside Awaits in the Dynamic Cardiac Monitoring Market - DirectorsTalk Interviews
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference - manilatimes.net
Is iRhythm Holdings Inc (IRTC) a Bargain After 3.2% Drop? GF Val - GuruFocus
IRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference - Moomoo
iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds - Yahoo Finance
iRhythm (IRTC) Quarterly Scorecard: The Bottom-Line Figure Beats Its Comparison in Latest Trading; Stock Move: The Stock Loses 1.14% in the Latest SessionEarnings Acceleration Picks - vinanet.vn
iRhythm Holdings, Inc. (IRTC) Investor Outlook: Analyzing a 37% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
iRhythm (IRTC) Shares: Gains 0.42% to Reach $128.52 in the Current Update; Chart Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionUnusual Call Volume - vinanet.vn
iRhythm: The Algorithmic Margin Inflection Changes The Story (NASDAQ:IRTC) - Seeking Alpha
RTW INVESTMENTS, LP Buys iRhythm Holdings Inc (IRTC) -- Shares L - GuruFocus
iRhythm (IRTC) Levels: Gains 2.44% to Reach $127.80 for the Current Session; Level Watch: Price Remains Between $121.41 Support and $134.19 Resistance in the Current UpdateCash Secured Put - siam.in
iRhythm (IRTC) Levels: Gains 2.44% to Reach $127.80 for the Current Session; Level Watch: Price Remains Between $121.41 Support and $134.19 Resistance in the Current UpdateRip Sell Trade - vinanet.vn
Q2 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and Irhythm Technologies (IRTC) - The Globe and Mail
2 Reasons to Like IRTC (and 1 Not So Much) - Yahoo Finance
iRhythm (IRTC) Quarterly Figures: EPS Beats Its Estimate on the Day; Post-Earnings: Shares Finish 1.44% Down on the DayRevenue Report - vinanet.vn
Why iRhythm Holdings (IRTC) Is Down 6.3% After Raising 2026 Guidance and Cutting LossesAnd What's Next - simplywall.st
Why iRhythm Holdings (IRTC) Is Down 6.3% After Raising 2026 Guidance and Cutting LossesAnd What's Next - simplywall.st
IRTC Maintained by Wells Fargo -- Price Target Lowered to $168 - GuruFocus
Wells Fargo & Company Issues Pessimistic Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Sahm
Citizens Financial Group Inc. RI Buys New Shares in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Stock Price Down 6%Here's Why - MarketBeat
iRhythm Holdings (IRTC) Stock Analysis: A 39.87% Upside Opportunity in the Medical Device Sector - DirectorsTalk Interviews
The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call - Yahoo! Finance Canada
The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call - Yahoo Finance
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform - Zacks Investment Research
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform - Yahoo Finance
RTW Investments (IRTC) discloses 6.6% iRhythm stake via 2.18M shares - Stock Titan
Assenagon Asset Management S.A. Sells 248,060 Shares of iRhythm Technologies $IRTC - MarketBeat
Brian Yoor Steps Down from iRhythm Holdings Board; Karen McGinnis Named Audit Committee Chair - Kalkine Media
Artisan Partners group (IRTC) discloses 5.1% iRhythm Holdings position - Stock Titan
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Irhythm Holdings Inc Stock (IRTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Murphy Patrick Michael | CBO and CLO |
Aug 10 '26 |
Sale |
124.65 |
7,093 |
884,156 |
69,699 |
| Blackford Quentin S. | President and CEO |
Aug 10 '26 |
Sale |
124.65 |
26,859 |
3,348,012 |
226,008 |
| Patterson Chad | CHIEF COMM & PRODUCT OFFICER |
Aug 10 '26 |
Sale |
124.65 |
7,093 |
884,170 |
62,125 |
| Shrishrimal Sumi | EVP, Chief Risk Officer |
Aug 10 '26 |
Sale |
124.65 |
5,372 |
669,641 |
44,621 |
| Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH |
Aug 10 '26 |
Sale |
124.65 |
7,093 |
884,151 |
60,116 |
| Smith Mervin | EVP Strategic Business Ops |
Aug 03 '26 |
Sale |
122.12 |
617 |
75,349 |
22,410 |
| Rodda Julianne | EVP, CHIEF PEOPLE OFFICER |
Aug 03 '26 |
Sale |
122.12 |
2,112 |
257,919 |
18,201 |
| Patterson Chad | CHIEF COMM & PRODUCT OFFICER |
Aug 03 '26 |
Sale |
122.12 |
2,712 |
331,192 |
55,629 |
| Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH |
Jul 02 '26 |
Sale |
124.71 |
1,423 |
177,462 |
53,620 |
| Freeman Sean Clinton | EVP, Strategy & Corp Devt |
Jul 02 '26 |
Sale |
124.71 |
918 |
114,484 |
13,641 |
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):